Novel Treatment Strategies for Glioblastoma

Novel Treatment Strategies for Glioblastoma

This book is a compilation of articles that brings together current knowledge from an international team of contributors who are dedicated investigators exploring novel strategies for the treatment of glioblastoma. These articles describe some of the latest concepts that will provide students, resea...

Full description

Saved in:
Bibliographic Details
Sonstige:
Stylli, Stanley
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (268 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545726004498
ctrlnum (CKB)5400000000042255
(oapen)https://directory.doabooks.org/handle/20.500.12854/77121
(EXLCZ)995400000000042255
collection bib_alma
record_format marc
spelling Stylli, Stanley edt
Novel Treatment Strategies for Glioblastoma
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
1 electronic resource (268 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
This book is a compilation of articles that brings together current knowledge from an international team of contributors who are dedicated investigators exploring novel strategies for the treatment of glioblastoma. These articles describe some of the latest concepts that will provide students, researchers and clinicians with an overview of the therapeutic approaches being developed in the field of neuro-oncology to combat this deadly disease.
English
Medicine bicssc
glioblastoma
glioma
temozolomide
radiotherapy
immunotherapy
novel therapy
personalized treatment
drug repurposing
invasion
invadopodia
ion channels
gene therapy
viral vectors
brain tumor
nanomedicine
cancer stem cell
targeted therapy
brain cancer
cell cycle
differentiation
proliferation
RAS
SRGAP2
stem cell
TP53
glioblastoma multiforme
GBM
nerve/glial antigen 2
NG2
CK2
CX-4945
migration
CRISPR/Cas9
anticancer
anti-angiogenesis
thyrointegrin αvβ3
PEG
triazole tetrac
P-bi-TAT
P-m-TAT
tetrac
one-carbon metabolism
de novo purine synthesis
metabolic reprogramming
metabolic treatment
vaccine
immune checkpoint inhibitors
chimeric antigen receptor (CAR) T cells
glioblastoma (GB)
prolyl-oligopeptidase (POP)
vascular endothelial growth factor (VEGF)
transforming growth factor-β (TGF-β)
angiopoietin (Ang)
endothelial nitric oxide synthase (eNOS)
newly diagnosed glioblastoma
recurrent glioblastoma
new trial design
drug-inducible gene expression
Mardepodect
Regorafenib
drug targets
tumor antigens
renin-angiotensin system
pluripotent stem cells
organoids
cancer stem cells
cancer stem cell niche
tumor microenvironment
3-0365-2599-8
3-0365-2598-X
Stylli, Stanley oth
language English
format eBook
author2 Stylli, Stanley
author_facet Stylli, Stanley
author2_variant s s ss
author2_role Sonstige
title Novel Treatment Strategies for Glioblastoma
spellingShingle Novel Treatment Strategies for Glioblastoma
title_full Novel Treatment Strategies for Glioblastoma
title_fullStr Novel Treatment Strategies for Glioblastoma
title_full_unstemmed Novel Treatment Strategies for Glioblastoma
title_auth Novel Treatment Strategies for Glioblastoma
title_new Novel Treatment Strategies for Glioblastoma
title_sort novel treatment strategies for glioblastoma
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2021
physical 1 electronic resource (268 p.)
isbn 3-0365-2599-8
3-0365-2598-X
illustrated Not Illustrated
work_keys_str_mv AT styllistanley noveltreatmentstrategiesforglioblastoma
status_str n
ids_txt_mv (CKB)5400000000042255
(oapen)https://directory.doabooks.org/handle/20.500.12854/77121
(EXLCZ)995400000000042255
carrierType_str_mv cr
is_hierarchy_title Novel Treatment Strategies for Glioblastoma
author2_original_writing_str_mv noLinkedField
_version_ 1787548726630285312
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03574nam-a2201105z--4500</leader><controlfield tag="001">993545726004498</controlfield><controlfield tag="005">20231214133343.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202201s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000042255</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/77121</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000042255</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Stylli, Stanley</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Novel Treatment Strategies for Glioblastoma</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (268 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book is a compilation of articles that brings together current knowledge from an international team of contributors who are dedicated investigators exploring novel strategies for the treatment of glioblastoma. These articles describe some of the latest concepts that will provide students, researchers and clinicians with an overview of the therapeutic approaches being developed in the field of neuro-oncology to combat this deadly disease.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glioblastoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glioma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">temozolomide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">novel therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personalized treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug repurposing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">invasion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">invadopodia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ion channels</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gene therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">viral vectors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain tumor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanomedicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer stem cell</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell cycle</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">differentiation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proliferation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RAS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SRGAP2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">stem cell</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TP53</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glioblastoma multiforme</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GBM</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nerve/glial antigen 2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NG2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CK2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CX-4945</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">migration</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CRISPR/Cas9</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anticancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anti-angiogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">thyrointegrin αvβ3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PEG</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">triazole tetrac</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">P-bi-TAT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">P-m-TAT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tetrac</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">one-carbon metabolism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">de novo purine synthesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metabolic reprogramming</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metabolic treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune checkpoint inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chimeric antigen receptor (CAR) T cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glioblastoma (GB)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prolyl-oligopeptidase (POP)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vascular endothelial growth factor (VEGF)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">transforming growth factor-β (TGF-β)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">angiopoietin (Ang)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endothelial nitric oxide synthase (eNOS)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">newly diagnosed glioblastoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">recurrent glioblastoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">new trial design</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug-inducible gene expression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mardepodect</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Regorafenib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug targets</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor antigens</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">renin-angiotensin system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pluripotent stem cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">organoids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer stem cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer stem cell niche</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor microenvironment</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2599-8</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2598-X</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stylli, Stanley</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:51:10 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338050360004498&amp;Force_direct=true</subfield><subfield code="Z">5338050360004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338050360004498</subfield></datafield></record></collection>

Similar Items